DiviDrip · ERNA

ERNA — Ernexa Therapeutics Inc.

ERNA is Ernexa Therapeutics Inc. (Healthcare) — a non-dividend-paying stock. Trading at $4.57. Market cap: $5M. Capital Quality Rank: 8/100 — Systemic risk.

Stock snapshot

Price$4.57
Market cap$5M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)8 / 100 · Systemic risk
ROIC (TTM)-788.9%
Shareholder buyback yield-30.00%
Altman Z-score zoneDistress

About ERNA

Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the intrinsic tumor-homing ability of MSCs (mesenchymal stem cells) to slip through the tumor's defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment. The firm's initial focus is to develop ERNA-101 in platinum-resistant ovarian cancer. Through another product candidate, ERNA-201, it is investigating anti-inflammatory cytokine (IL-10) secreting iMSCs in autoimmune disorders like rheumatoid arthritis. The company operates in a single reportable segment, the research and development of cellular therapies.

Listed2021Employees5HQCambridge, MASectorHealthcareWebsiteernexatx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside ERNA. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is ERNA's current stock price?

ERNA (Ernexa Therapeutics Inc.) is currently trading at $4.57.

Does ERNA pay a dividend?

ERNA (Ernexa Therapeutics Inc.) does not currently pay a regular dividend.

What is ERNA's Capital Quality Rank?

ERNA has a Capital Quality Rank of 8/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track ERNA in DiviDrip

Add ERNA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow